Glofitamab,Obinutuzumab,Tocilizumab
roche
['glofitamab', 'lymsm', 'lymphoma', 'dlbcl']
#ash22 #lymsm #dlbcl hutchings et al glofitamab in rr dlbcl
fixed duration 12 cycles 35.4% cr for pts in cr: 24 mo cr 79%
12 mo pfs 92.6% full dataset in today 
Clinician-researcher-educator bookworm @RoswellPark. Passionate about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews